Skip to main content
. 2020 Jun 30;3(6):e207227. doi: 10.1001/jamanetworkopen.2020.7227

Table 3. Multivariable Fine-Gray Competing Risk Models for Breast Cancer–Specific Mortality: Comparison of Interval Breast Cancers and Breast Cancers Detected by Screening After Controlling for Baseline Health and Tumor Characteristics.

Model Breast cancer type, hazard ratio (95% CI)a
Detected by screening Interval breast cancer <1 y Interval breast cancer 1-2.5 y
1b 1 [Reference] 1.81 (1.30-2.51) 1.17 (0.88-1.56)
2c 1 [Reference] 1.64 (1.17-2.29) 1.12 (0.83-1.50)
3d 1 [Reference] 1.66 (1.18-2.33) 1.17 (0.86-1.60)
4e 1 [Reference] 1.69 (1.20-2.37) 1.17 (0.86-1.60)
5f 1 [Reference] 1.46 (1.03-2.08) 1.12 (0.82-1.53)
6g 1 [Reference] 1.34 (0.96-1.88) 1.13 (0.83-1.55)
7h,i 1 [Reference] 1.24 (0.87-1.77) 1.09 (0.79-1.51)
a

This table reports a series of sequential multivariable models in which a new variable is added to each model. Numbers in cells represent the hazard ratios and 95% CIs computed from the Fine-Gray competing risk model. Time is calculated as the time between diagnosis date and end of follow-up. Interval breast cancers were subdivided by their interscreening period: those diagnosed within 1 year of last screening or between 1 and 2.5 years since last screening.

b

Fine-Gray competing risk models for breast cancer–specific mortality by breast cancer type adjusting for molecular subtype as the covariate.

c

Includes all variables in model 1 with additional adjustment for histologic type.

d

Includes all variables in model 2 with additional adjustment for hormone replacement therapy clinical trial group and dietary modification trial group.

e

Includes all variables in model 3 with additional adjustment for waist to hip ratio.

f

Includes all variables in model 4 with additional adjustment for tumor size.

g

Includes all variables in model 5 with additional adjustment for lymph node involvement.

h

Includes all variables in model 6 with additional adjustment for other common risk factors for breast cancer (age at diagnosis, race/ethnicity, family history of breast cancer, comorbidity, total number of mammograms before diagnosis, age at menarche, age at first birth, income, educational level, smoking status, alcohol intake, and body mass index).

i

If adding the common risk factors in model 7 before adding tumor size and lymph node into the model, the corresponding hazard ratio for interval breast cancer within 1 year is 1.64 (95% CI, 1.14-2.34) and for interval breast cancer between 1 and 2.5 years is 1.16 (95% CI, 0.84-1.59).